Press Release

Law firm Shoosmiths has advised venture capital (VC) firm Lakestar on its investment as part of a £35 million Series B investment round into Doccla, a pioneering virtual hospital ward startup. Founded in Sweden, Doccla provides continuous virtual monitoring, enabling medical staff to receive real-time updates on patient conditions. The company entered the UK market in 2020 with an initial pilot ward, and the Covid-19 pandemic significantly increased the demand for its innovative products.

The investment was spearheaded by Shoosmiths' VC team, which has been recognised as the most active law firm advising on VC transactions for three consecutive years (according to PitchBook’s global league tables). The Shoosmiths team was led by corporate partner Alistair Hammerton, supported by principal associate Charlotte Cannell and associate Hugh White. 

Lakestar Partner and new Doccla board member Oliver Heimes commented: “In less than five years Doccla has gone from a research project to establishing itself as the market leader in the UK. We are confident they will not just maintain that position but successfully launch in new markets, whilst diversifying their services. Remote patient care delivers proven results and is ushering in new standards in the healthcare systems globally.”

Alistair Hammerton, corporate partner at Shoosmiths added: “It was a pleasure to advise on this funding round, with Doccla being highly regarded as a market leader in the UK healthtech space. This fresh funding will enable Doccla to expand across Europe, and Shoosmiths is proud to play a pivotal role in their Series B funding round which will see them entering an exciting new chapter of further growth.”